ID
23242
Description
Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00602511
Link
https://clinicaltrials.gov/show/NCT00602511
Keywords
Versions (1)
- 6/30/17 6/30/17 -
Uploaded on
June 30, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Multiple Myeloma NCT00602511
Eligibility Multiple Myeloma NCT00602511
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
ID.4
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1176309
- UMLS CUI [1,2]
- C0039736
- UMLS CUI [1,3]
- C1144149
Description
ID.5
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0151313
- UMLS CUI [1,2]
- C0003892
Description
ID.6
Data type
boolean
Alias
- UMLS CUI [1]
- C0012634
Description
ID.7
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0023484
- UMLS CUI [1,2]
- C0024299
- UMLS CUI [1,3]
- C0580822
Description
ID.8
Data type
boolean
Alias
- UMLS CUI [1]
- C4276228
Description
ID.9
Data type
boolean
Alias
- UMLS CUI [1]
- C1321605
Description
ID.10
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
Description
ID.11
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1321605
- UMLS CUI [1,2]
- C0032961
Description
ID.12
Data type
boolean
Alias
- UMLS CUI [1]
- C0040034
Similar models
Eligibility Multiple Myeloma NCT00602511
- StudyEvent: Eligibility
C0205269 (UMLS CUI [1,2])
C0039736 (UMLS CUI [1,2])
C1144149 (UMLS CUI [1,3])
C0003892 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,2])
C0580822 (UMLS CUI [1,3])
C0032961 (UMLS CUI [1,2])